Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation / Developmental Disabilities

NCT00298818 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT00298818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00298818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation / Developmental Disabilities
Lead sponsor
Northwell Health
Phase
Observational
Overall status
Completed
Start date
August 31, 2002
Completion date
March 31, 2008
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

developmental disabilities, epilepsy, mental retardation